Definium Therapeutics, Inc. (DFTX)
37.46
+0.38
(+1.02%)
USD |
NASDAQ |
Oct 28, 10:38
Definium Therapeutics Price : 37.46 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 35.42 | 37.61 | 35.18 | 37.08 | 1.282M |
| Oct 26, 2026 | 35.60 | 36.35 | 34.74 | 35.68 | 1.054M |
| Oct 23, 2026 | 36.01 | 36.12 | 35.09 | 35.67 | 1.755M |
| Oct 22, 2026 | 35.29 | 36.23 | 35.09 | 36.00 | 2.093M |
| Oct 21, 2026 | 35.46 | 36.34 | 35.04 | 35.49 | 2.906M |
| Oct 20, 2026 | 32.99 | 35.58 | 32.78 | 35.09 | 1.746M |
| Oct 19, 2026 | 32.28 | 33.30 | 32.23 | 32.97 | 1.736M |
| Oct 16, 2026 | 34.07 | 34.15 | 32.02 | 32.10 | 1.935M |
| Oct 15, 2026 | 34.23 | 34.79 | 33.92 | 34.26 | 1.748M |
| Oct 14, 2026 | 34.20 | 34.91 | 33.65 | 34.24 | 1.762M |
| Oct 13, 2026 | 34.83 | 34.95 | 34.03 | 34.38 | 2.000M |
| Oct 12, 2026 | 36.27 | 36.30 | 34.95 | 35.20 | 1.909M |
| Oct 09, 2026 | 34.85 | 38.04 | 34.57 | 36.90 | 2.774M |
| Oct 08, 2026 | 34.62 | 34.88 | 32.84 | 34.18 | 2.104M |
| Oct 07, 2026 | 35.34 | 36.39 | 34.92 | 35.09 | 1.967M |
| Oct 06, 2026 | 36.55 | 36.55 | 34.38 | 35.62 | 2.481M |
| Oct 05, 2026 | 37.50 | 37.74 | 35.90 | 36.23 | 2.602M |
| Oct 02, 2026 | 37.70 | 38.14 | 36.86 | 37.40 | 1.599M |
| Oct 01, 2026 | 37.94 | 38.95 | 37.29 | 37.60 | 2.121M |
| Sep 30, 2026 | 38.42 | 38.80 | 37.32 | 38.06 | 2.381M |
| Sep 29, 2026 | 38.32 | 38.70 | 37.44 | 38.21 | 1.967M |
| Sep 28, 2026 | 35.92 | 39.10 | 35.51 | 38.41 | 2.994M |
| Sep 25, 2026 | 37.00 | 37.00 | 36.14 | 36.17 | 2.683M |
| Sep 24, 2026 | 37.49 | 37.60 | 35.89 | 36.73 | 2.309M |
| Sep 23, 2026 | 40.03 | 40.04 | 37.16 | 37.65 | 2.713M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enliven Therapeutics, Inc. | 44.34 |
| Cocrystal Pharma, Inc. | 0.9809 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| Arvinas, Inc. | 7.47 |
| Fulcrum Therapeutics, Inc. | 3.72 |
Price Related Metrics
| PEG Ratio | -0.0807 |
| Price to Book Value | 5.479 |
| Earnings Yield | -9.18% |
| Market Cap | 5.033B |
| PEGY Ratio | -0.0807 |